China Covid-19 vaccine trial atan mi 50,000 inpe

China-in Covid-19 vaccine siam chhuah tumna kawngah Phase 3 clinical trial a neihna tur atana inpe mi 50,000 an awm. 

He vaccine hi  China National Biotec Group (CNBG) siam a ni a, mihringa enchhinna neihna tura inpe te hi ram hrang hrang mite an nih thu a sawi bawk. 

China bakah Bahrain, UAE, Morocco, Peru leh Argentina-ahte phase 3 clinical trail hi neih tum a ni. July thla khan China Covid-19 vaccine phase 3 trial hi Uzbekistan leh Pakistan-ahte pawh neih tum a nih thu media-te chuan an lo tarlang tawh bawk.